Brachytherapy plus EBRT reduces the risk of ECE in prostate cancer patients

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2007年 / 4卷 / 6期
关键词：
D O I：
10.1038/ncpuro0790
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：295 / 295
相关论文
共 50 条
  • [21] Can EBRT Dose-Escalation Above 80 Gy Yield Comparable Survival Rates Relative to EBRT Plus Brachytherapy Boost in Men With Unfavorable Intermediate-Risk Prostate Cancer?
    Andruska, N.
    Diaz, E. Juarez
    Gay, H. A.
    Agabalogun, T.
    Waters, M. R.
    Brenneman, R. J.
    Michalski, J. M.
    Fischer-Valuck, B. W.
    Baumann, B. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E264 - E264
  • [22] External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: Whole pelvis or prostate-only EBRT?
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Hoskin, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Single-fraction HDR brachytherapy boost in combination to EBRT for prostate cancer
    Huertas, A.
    Blanchard, P.
    Calmels, L.
    Edouard, M.
    Bossi, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S710 - S710
  • [24] Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
    Moll, Matthias
    Renner, Andreas
    Kirisits, Christian
    Paschen, Christopher
    Zaharie, Alexandru
    Goldner, Gregor
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (11) : 986 - 992
  • [25] Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
    Matthias Moll
    Andreas Renner
    Christian Kirisits
    Christopher Paschen
    Alexandru Zaharie
    Gregor Goldner
    [J]. Strahlentherapie und Onkologie, 2021, 197 : 986 - 992
  • [26] Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
    Moll, Matthias
    Magrowski, Lukasz
    Mittlboeck, Martina
    Heinzl, Harald
    Kirisits, Christian
    Ciepal, Jakub
    Masri, Oliwia
    Heilemann, Gerd
    Stando, Rafal
    Krzysztofiak, Tomasz
    Depowska, Gabriela
    d'Amico, Andrea
    Techmanski, Tomasz
    Kozub, Anna
    Majewski, Wojciech
    Suwinski, Rafal
    Wojcieszek, Piotr
    Sadowski, Jacek
    Widder, Joachim
    Goldner, Gregor
    Miszczyk, Marcin
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2024,
  • [27] Cervical Cancer Outcomes in Elderly Women Treated with EBRT and Brachytherapy plus /- Concurrent Chemotherapy
    Niewold, N.
    Ko, H. C.
    Straub, M. R.
    Bradley, K. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E333 - E333
  • [28] Evaluation of Rectal Dose in Prostate Cancer Patients Having Hydrogel Spacer Insertion in LDR Brachytherapy and EBRT Radiotherapy
    Zhang, H.
    Wang, L.
    Riegel, A. C.
    Antone, J.
    Potters, L.
    Lee, L.
    Cao, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E745 - E745
  • [29] A Matched Comparison of High-Risk Prostate Cancer Patients Treated With Dose-Escalated, Image Guided Adaptive External Beam Radiation Therapy (EBRT) Versus Pelvic EBRT Plus High-Dose-Rate Brachytherapy Boost
    Blas, K. G.
    Brown, M. E.
    Wallace, M.
    Tonlaar, N. Y.
    Stone, B. M.
    Chen, P. Y.
    Gustafson, G. S.
    Brabbins, D. S.
    Yan, D.
    Ye, H.
    Krauss, D. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S121 - S122
  • [30] Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone
    Fang, Fu-Min
    Wang, Yu-Ming
    Wang, Chong-Jong
    Huang, Hsuan-Ying
    Chiang, Po-Hui
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 474 - 479
12345